⌘K

Home/Filings/4/0001562180-25-002143

4//SEC Filing

Capers Dorothy Trefon 4

Accession 0001562180-25-002143

CIK 0001524472other

View on SEC.gov Company Profile

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:11 PM ET

Size

17.2 KB

Accession

0001562180-25-002143

Insider Transaction Report

Form 4

Period: 2025-03-04

Capers Dorothy Trefon

SVP & General Counsel

Transactions

Exercise/Conversion
Common Stock
2025-03-04$86.76/sh+7,868$682,628→ 15,883 total
Exercise/Conversion
Common Stock
2025-03-04$101.09/sh+4,158$420,332→ 20,041 total
Sale
Common Stock
2025-03-04$127.26/sh−12,026$1,530,391→ 8,015 total
Award
Common Stock
2025-03-05$129.67/sh+1,398$181,279→ 9,413 total
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2025-03-04−4,158→ 2,079 total
Exercise: $101.09Exp: 2033-03-01→ Common Stock (4,158 underlying)
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2025-03-04−7,868→ 0 total
Exercise: $86.76Exp: 2032-03-01→ Common Stock (7,868 underlying)
Award
Non-Qualified Stock Options (Right to buy)
2025-03-05$129.67/sh+4,905$636,031→ 4,905 total
Exercise: $129.67Exp: 2035-03-05→ Common Stock (4,905 underlying)

Footnotes (5)

[F1]This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 12,026 Shares were executed at a range of prices from $125.25 to $125.35. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
[F2]Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028.
[F3]The March 1, 2023 option grant vested 2,079 options on March 1, 2024, 2,079 options on March 1, 2025, and will vest 2,079 options on March 1, 2026.
[F4]The March 1, 2022 option grant vested 2,623 options on March 1, 2023, 2,623 options on March 1, 2024, and 2,622 options on March 1, 2025.
[F5]Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

Xylem Inc.

CIK 0001524472

Entity typeother

Related Parties

1

filerCIK 0001905353

Filing Metadata

Form type: 4
Filed: Mar 5, 7:00 PM ET
Accepted: Mar 6, 4:11 PM ET
Size: 17.2 KB

View on SEC.gov